IPO Analysis: Equitas Small Finance Bank IPO Analysis: Equitas Small Finance Bank Equitas Small Finance Bank is hitting the primary capital market with its IPO. Read on to find out if you should subscribe to the issue.
IPO Analysis: Mazagon Dock Shipbuilders IPO Analysis: Mazagon Dock Shipbuilders Mazagon Dock Shipbuilders, the defence public sector undertaking shipyard, is hitting the primary capital market with its IPO. Read on to find out if you should subscribe to the issue.
IPO Analysis: Likhitha Infrastructure IPO Analysis: Likhitha Infrastructure Likhitha Infrastructure, a Hyderabad-based company engaged in oil & gas pipeline infrastructure in India, is hitting the primary capital market with its IPO. Read on to find out if you should subscribe to the issue.
IPO Analysis: UTI Asset Management Company IPO Analysis: UTI Asset Management Company UTI AMC, the second-largest asset management company in India is hitting the primary capital market with its IPO. Read on to find out if you should subscribe to the issue.
IPO analysis: Angel Broking IPO analysis: Angel Broking Angel Broking, one of the largest retail broking houses in India in terms of active clients on NSE, is coming out with its IPO today. Read on to find out if you should subscribe to the issue.
Cipla receives final USFDA approval for Efavirenz Cipla receives final USFDA approval for Efavirenz Nikita Singh / 20-Jun-2018, 04:21 PM / Article rating: 4.3 Multinational pharma company, Cipla posted a 3 per cent hike in its share price as the company received final approval for its new drug application (ANDA) for Efavirenz tablets 600mg from the United States Food and Drug Administration (USFDA).
Alembic continues rally as Panelav unit receives EIR Alembic continues rally as Panelav unit receives EIR Nikita Singh / 15-Jun-2018, 12:36 PM / Article rating: 3.0 The share price of pharma major Alembic Pharmaceuticals continued to surge in Friday’s trading session. The share price grew by 7 per cent on Friday as the company bagged EIR for its formulation facility at Panelav, Gujarat from the US Food and Drugs Association.
Overnight Digest: Stocks to look out for on June 15 Overnight Digest: Stocks to look out for on June 15 Nikita Singh / 14-Jun-2018, 06:33 PM / Article rating: 5.0 The stocks that are likely to record significant movement on the bourses on Friday, June 15 are HIL Limited, Wipro Limited, Maha Rashtra Apex Corporation Limited and Hind Aluminium Industries Limited.
Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Cipla bags USFDA approval for Isoproterenol Hydrochloride injection Nikita Singh / 14-Jun-2018, 12:52 PM / Article rating: 3.5 The share price of Cipla surged by nearly 2 per cent in the early trade on Thursday as the company received the USFDA approval for Isoproterenol Hydrochloride injection, a generic version of Hospira Inc’s Isuprel injection.
Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Alembic receives USFDA approval for Doxycycline Hyclate, up 8 per cent Nikita Singh / 14-Jun-2018, 12:29 PM / Article rating: 5.0 Pharma major Alembic Pharmaceuticals bagged the approval of US Food and Drugs Association for its abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules.